[go: up one dir, main page]

HK1031824A1 - Parenteral formulations comprising 10-hydroxy-10, 11-tetrahydrocarbamazepine, water and glucose - Google Patents

Parenteral formulations comprising 10-hydroxy-10, 11-tetrahydrocarbamazepine, water and glucose Download PDF

Info

Publication number
HK1031824A1
HK1031824A1 HK01101037A HK01101037A HK1031824A1 HK 1031824 A1 HK1031824 A1 HK 1031824A1 HK 01101037 A HK01101037 A HK 01101037A HK 01101037 A HK01101037 A HK 01101037A HK 1031824 A1 HK1031824 A1 HK 1031824A1
Authority
HK
Hong Kong
Prior art keywords
glucose
water
parenteral formulation
compound
containers
Prior art date
Application number
HK01101037A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1031824B (en
Inventor
Van Hoogevest Peter
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1031824A1 publication Critical patent/HK1031824A1/en
Publication of HK1031824B publication Critical patent/HK1031824B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
HK01101037.2A 1997-10-09 1998-10-07 Parenteral formulations comprising 10-hydroxy-10, 11-tetrahydrocarbamazepine, water and glucose HK1031824B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9721497.7A GB9721497D0 (en) 1997-10-09 1997-10-09 Organic compounds
GB9721497.7 1997-10-09
PCT/EP1998/006382 WO1999018966A1 (en) 1997-10-09 1998-10-07 Parenteral formulations comprising carbamazepine or its derivatives

Publications (2)

Publication Number Publication Date
HK1031824A1 true HK1031824A1 (en) 2001-06-29
HK1031824B HK1031824B (en) 2004-09-24

Family

ID=

Also Published As

Publication number Publication date
BR9812861A (pt) 2000-08-08
HUP0004362A3 (en) 2006-06-28
DE69821024T2 (de) 2004-10-28
NO20001730D0 (no) 2000-04-04
KR20010072533A (ko) 2001-07-31
CZ20001279A3 (cs) 2000-07-12
JP2001519395A (ja) 2001-10-23
HUP0004362A2 (hu) 2001-08-28
PE121998A1 (es) 1999-12-08
NO20001730L (no) 2000-04-04
KR100760326B1 (ko) 2007-09-20
US6458770B1 (en) 2002-10-01
PL192287B1 (pl) 2006-09-29
AR015465A1 (es) 2001-05-02
SK286253B6 (sk) 2008-06-06
CO5090854A1 (es) 2001-10-30
ZA989183B (en) 1999-04-09
NZ503526A (en) 2003-01-31
US20020055503A1 (en) 2002-05-09
DK1033988T3 (da) 2004-04-13
RU2242231C2 (ru) 2004-12-20
CA2304661C (en) 2007-12-11
US6316417B1 (en) 2001-11-13
WO1999018966A1 (en) 1999-04-22
CN1210032C (zh) 2005-07-13
ATE257383T1 (de) 2004-01-15
PT1033988E (pt) 2004-05-31
CO4950520A1 (es) 2000-09-01
TR200000870T2 (tr) 2000-10-23
CN1274286A (zh) 2000-11-22
CA2304661A1 (en) 1999-04-22
ID24134A (id) 2000-07-06
AU748034B2 (en) 2002-05-30
HU226106B1 (en) 2008-04-28
PL339446A1 (en) 2000-12-18
NO327263B1 (no) 2009-05-25
JP2005281314A (ja) 2005-10-13
DE69821024D1 (de) 2004-02-12
AU9629898A (en) 1999-05-03
MY122129A (en) 2006-03-31
EP1033988B1 (en) 2004-01-07
IL135123A0 (en) 2001-05-20
CZ298900B6 (cs) 2008-03-05
TW584563B (en) 2004-04-21
GB9721497D0 (en) 1997-12-10
ES2214738T3 (es) 2004-09-16
SK5052000A3 (en) 2000-12-11
EP1033988A1 (en) 2000-09-13

Similar Documents

Publication Publication Date Title
JP6592150B2 (ja) 酢酸グラチラマーの製造方法
EP3363428B1 (en) Perfusion dosage form
AU777619B2 (en) Suspension comprising oxcarbazepine
WO2016203497A1 (en) A ready-to-administer solution of fentanyl citrate
KR20150132835A (ko) 변형된 가요성 플라스틱 용기에서 즉시 사용가능한 공용매 약학 조성물
EP1033988B1 (en) Parenteral formulations comprising 10-hydroxy-10,11-tetrahydrocarbamazepine, water and glucose
HK1031824B (en) Parenteral formulations comprising 10-hydroxy-10, 11-tetrahydrocarbamazepine, water and glucose
MXPA00003413A (en) Parenteral formulations comprising carbamazepine or its derivatives
WO2025057112A1 (en) Bupivacaine liquid formulations
UA144364U (uk) Спосіб лікування інфекційних захворювань бактеріальної етіології
EP3000461A1 (en) Parenteral dosage form of amiodarone
HK1050474B (en) Suspension comprising oxcarbazepine
HK1070267A (en) Suspension comprising oxcarbazepine
WO2000067753A1 (en) Parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate(clomethiazole edisylate)

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091007